Back

Design of a national Swedish study evaluating donor-derived cell-free DNA as a diagnostic biomarker in heart transplantation using next-generation sequencing

11 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation Transplantation HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ida Haugen Loefman

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Survival trajectories in post-transplant patients receiving "acceptably" undersized donor hearts: a long-term analysis
Doctor S. Kumar (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Predictors of heart failure rehospitalization in mitral transcatheter edge-to-edge repair (M-TEER) based on residual mitral regurgitation: a single center study
Doctor M. Biswas (Pittsburgh, US)
Abstract Slides
Presentation thumbnail
Endocarditis by candida spp and association with heart failure: a systematic review of case reports
Doctor C. Vigil Lopez (Ensenada, MX)
Abstract Slides
Presentation thumbnail
Persistent pulmonary hypertension after mitral valve surgery is related to post-operative adverse in-hospital events and mortality.
Miss R. Heijting (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Predictors of lv function recovery one year after TAVR
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Hemodynamics, prognostic markers, and precision monitoring in structural heart disease and heart transplantation

The Event

Event poster

Heart Failure 2026

11 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Silent threats and strategic solutions: surgical revascularization in diffuse cardiac allograft vasculopathy
thumbnail
Congress Session
Advanced heart failure, mechanical circulatory support, and transplant
thumbnail
Congress Presentation
Comprehensive non-invasive versus invasive approach to evaluate cardiac allograft vasculopathy in heart transplantation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources